The prothrombin 20210A allele influences clinical manifestations of hemophilia a in patients with intron 22 inversion and without inhibitors

Haematologica

Volumn 87, Issue 3, 2002, Pages 279-285

  Tizzaon, Eduardo F ^a   Soria, José Manuel ^a   Coll, Immaculada ^a   Guzmán, Blanca ^a   Cornet, Mönica ^a   Altisent, Carmen ^a   Martorell, Marta ^a   Domenech, Montserrat ^a   Del Rio, Elizabeth ^a   Fontcuberta, Jordi ^a   Baiget, Montserrat ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Bleeding; FVIII utilization; FVL; Hemophilia A; Hemophilic arthropathy; Inversion; PT20210A

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; DNA; PROTHROMBIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HEMOPHILIA A; HETEROZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; THROMBOEMBOLISM;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; FACTOR V; GENETIC SCREENING; HEMOPHILIA A; HEMORRHAGE; HUMANS; INFANT; INTRONS; INVERSION, CHROMOSOME; ISOANTIBODIES; PREVALENCE; PROTHROMBIN;

EID: 0036195046     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Platelet coagulant activities and clinical severity in haemophilia
2. Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo
3. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis
4. Moderation of hemophilia A phenotype by the factor V R506Q mutation
5. Association of severe hemophilia A and factor V Leiden. A report of three cases
6. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A
7. Mutation in blood coagulation factor V associated with resistance to activated protein C
8. Association of idiopathic thromboembolism with single point-mutation at Arg506 of factor V
9. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
10. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
11. Linkage analysis demonstrates than the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis
12. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population
13. A simple salting out procedure for extracting DNA from human nucleated celts
14. Inversion of the intron 22 in isolated cases of hemophilia A
15. Analysis of the essential sequences of the factor VIII gene in twelve haemophilia A patients by single-stranded conformation polymorphism
16. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene
17. Initial presentations of pediatric hemophiliacs
18. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors
19. Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene
20. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
21. High levels of coagulation factor XI as a risk factor for venous thrombosis
22. High levels of factor IX increase the risk of venous thrombosis
23. Genetic determinants of hemostasis phenotypes in Spanish families
24. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Genetic Analysis of Idiopathic Thrombophilia
25. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia
26. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic fmilies with other hemostatic deficiencies
27. Deep venous thrombosis in hemophilia A
28. Central venous catheter-associated thrombosis in severe haemophilia
29. Fatal myocardial infarction following therapy with prothombin complex concentrates in a young man with hemophilia A
30. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor
31. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor
32. Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding: Successful thrombolysis under heparin therapy